Skip to main content

Table 2 Non-hyperresponsive non-asthmatic participants demographics

From: The effect of glycopyrronium and indacaterol, as monotherapy and in combination, on the methacholine dose-response curve of mild asthmatics: a randomized three-way crossover study

Participant Gender Age (years) Height (cm) BMI (kg/m2) Mean FEV1/FVC Mean Baseline FEV1 (L) Mean Baseline FEV1 (% Predicted)
H01 F 25 163 20 0.76 3.64 112
H02 F 22 168 21 0.83 3.10 88
H03 F 18 180 21 0.90 3.31 82
H04 F 36 163 20 0.78 2.57 83
H05 M 26 180 24 0.80 4.83 103
H06 M 20 170 30 0.78 3.33 77
H07 M 20 170 28 0.71 3.77 88
H08 M 27 170 33 0.85 4.78 115
H09 M 29 164 25 0.90 3.43 90
H10 M 34 175 30 0.84 4.15 98
H11 F 47 173 24 0.75 3.30 101
H12 F 20 170 30 0.81 4.00 111
H13 F 22 168 19 0.87 3.44 99
H14 F 35 157 26 0.81 3.30 113
H15 M 64 178 28 0.80 2.90 84
Means: 47% Male 30 [12] 170 [7] 25 [4] 0.81 [0.05] 3.59 [0.63] 96 [13]
  1. BMI body mass index, FEV 1 , forced expiratory volume in 1 s, FVC forced vital capacity; [], standard deviation